Cargando…
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria()
Antibodies to selected Plasmodium falciparum merozoite antigens are often reported to be associated with protection from malaria in one epidemiological cohort, but not in another. Here, we sought to understand this paradox by exploring the hypothesis that a threshold concentration of antibodies is n...
Autores principales: | Murungi, Linda M., Kamuyu, Gathoni, Lowe, Brett, Bejon, Philip, Theisen, Michael, Kinyanjui, Samson M., Marsh, Kevin, Osier, Faith H.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763364/ https://www.ncbi.nlm.nih.gov/pubmed/23800539 http://dx.doi.org/10.1016/j.vaccine.2013.06.042 |
Ejemplares similares
-
Vaccine candidate discovery for the next generation of malaria vaccines
por: Tuju, James, et al.
Publicado: (2017) -
Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity
por: Rono, Josea, et al.
Publicado: (2015) -
Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria
por: Aniweh, Yaw, et al.
Publicado: (2020) -
KILchip v1.0: A Novel Plasmodium falciparum Merozoite Protein Microarray to Facilitate Malaria Vaccine Candidate Prioritization
por: Kamuyu, Gathoni, et al.
Publicado: (2018) -
What you see is not what you get: implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity
por: Kinyanjui, Samson M, et al.
Publicado: (2009)